NO901852D0 - Fremgangsmaate for fremstilling av liposomer. - Google Patents

Fremgangsmaate for fremstilling av liposomer.

Info

Publication number
NO901852D0
NO901852D0 NO1990901852A NO901852A NO901852D0 NO 901852 D0 NO901852 D0 NO 901852D0 NO 1990901852 A NO1990901852 A NO 1990901852A NO 901852 A NO901852 A NO 901852A NO 901852 D0 NO901852 D0 NO 901852D0
Authority
NO
Norway
Prior art keywords
procedure
liposomes
preparing liposomes
phospholipid
oligopeptide
Prior art date
Application number
NO1990901852A
Other languages
English (en)
Other versions
NO180363C (no
NO901852L (no
NO180363B (no
Inventor
Paul Gardener Schmidt
Gary Fujii
Original Assignee
Vestar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vestar Inc filed Critical Vestar Inc
Publication of NO901852D0 publication Critical patent/NO901852D0/no
Publication of NO901852L publication Critical patent/NO901852L/no
Publication of NO180363B publication Critical patent/NO180363B/no
Publication of NO180363C publication Critical patent/NO180363C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
NO901852A 1988-10-05 1990-04-26 Beskyttelsesmiddelblandinger for stabilisering av liposomer under törking NO180363C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25368088A 1988-10-05 1988-10-05
PCT/US1989/004222 WO1990003795A1 (en) 1988-10-05 1989-10-03 Method of making liposomes with improved stability during drying

Publications (4)

Publication Number Publication Date
NO901852D0 true NO901852D0 (no) 1990-04-26
NO901852L NO901852L (no) 1990-08-01
NO180363B NO180363B (no) 1996-12-30
NO180363C NO180363C (no) 1997-04-09

Family

ID=22961272

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901852A NO180363C (no) 1988-10-05 1990-04-26 Beskyttelsesmiddelblandinger for stabilisering av liposomer under törking

Country Status (13)

Country Link
US (1) US5817334A (no)
EP (1) EP0437479B1 (no)
JP (1) JP2792702B2 (no)
AT (1) ATE107502T1 (no)
AU (1) AU612285B2 (no)
CA (1) CA2000219A1 (no)
DE (1) DE68916439T2 (no)
DK (1) DK59691A (no)
FI (1) FI902249A0 (no)
IE (1) IE64559B1 (no)
IL (1) IL91901A (no)
NO (1) NO180363C (no)
WO (1) WO1990003795A1 (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705187A (en) * 1989-12-22 1998-01-06 Imarx Pharmaceutical Corp. Compositions of lipids and stabilizing materials
AU2583892A (en) * 1991-09-11 1993-04-05 Pitman-Moore, Inc. Method for enhancing the immune system in a host employing liposome-encapsulated polypeptides
JP3329554B2 (ja) * 1993-03-10 2002-09-30 千葉製粉株式会社 乾燥小胞体
DE4341472A1 (de) * 1993-12-02 1995-06-08 Schering Ag Verfahren zur Erhöhung der Stabilität von hydrophile Wirkstoffe enthaltenden Liposomensuspensionen
US5589189A (en) * 1994-09-14 1996-12-31 Nexstar Pharmaceuticals, Inc. Liposome dispersion
CA2202103C (en) * 1996-04-11 2007-01-09 Toshiaki Tagawa Method for preparing closed vesicles
GB9813100D0 (en) * 1998-06-18 1998-08-19 Secr Defence Method of forming liposomes
CA2364257A1 (en) * 1999-03-11 2000-09-14 Fujisawa Pharmaceutical Co., Ltd. Liposome preparations
CA2309373A1 (en) * 1999-05-27 2000-11-27 Johnson & Johnson Consumer Companies, Inc. Novel topical formulations
DK1059092T3 (da) * 1999-06-08 2006-03-27 Gentium Spa Anvendelse af komplekser af kationiske liposomer og polydeoxyribonukleotider som medikamenter
AU762944B2 (en) * 1999-06-23 2003-07-10 Cornell Research Foundation Inc. Dehydration/rehydration of marked liposomes on a test device
US6576460B1 (en) 1999-10-28 2003-06-10 Cornell Research Foundation, Inc. Filtration-detection device and method of use
WO2002038128A1 (fr) * 2000-11-10 2002-05-16 Japan Science And Technology Corporation Procede de preparation d'une dispersion de microsome
US7125568B2 (en) * 2001-08-23 2006-10-24 Sung Michael T Lipophilic drug compositions
AU2002340669A1 (en) * 2001-11-13 2003-05-26 Celator Technologies, Inc. Lipid carrier compositions with enhanced blood stability
DE60318435T2 (de) 2002-05-31 2008-12-24 Cornell Research Foundation, Inc. Universeller biosensor und verfahren zur verwendung
DE10233632A1 (de) * 2002-07-24 2004-02-05 Wilex Ag Formulierungen von Phenylalanin-Derivaten
WO2004017944A1 (en) * 2002-08-23 2004-03-04 Neopharm, Inc. Liposomal gemcitabine compositions for better drug delivery
CA2505520C (en) * 2002-11-06 2012-07-17 Azaya Therapeutics, Inc. Protein-stabilized liposomal formulations of pharmaceutical agents
EP1578193A4 (en) 2002-12-23 2011-06-15 Vical Inc FREEZING PROCESS FOR NUCLEIC ACID / BLOCK COPOLYMER / CATION SIDE COMPLEXES
WO2004060363A1 (en) * 2002-12-23 2004-07-22 Vical Incorporated Method for producing sterile polynucleotide based medicaments
WO2005020893A2 (en) * 2003-08-06 2005-03-10 The Regents Of The University Of California Therapeutic platelets and methods
EP1750673B1 (en) * 2004-05-17 2009-12-02 Tekmira Pharmaceuticals Corporation Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
FR2870741B1 (fr) * 2004-05-25 2008-03-14 Coletica Sa Phase lamellaires hydratees ou liposomes, contenant une monoamine grasse ou un polymere cationique favorisant la penetration intercellulaire, et composition cosmetique ou pharmaceutique la contenant.
WO2006050327A2 (en) * 2004-10-28 2006-05-11 Alza Corporation Lyophilized liposome formulations and method
WO2006068759A2 (en) * 2004-11-22 2006-06-29 Magellan Companies, Inc. Liposomes containing phytochemical agents and methods for making and using same
EP1932517A3 (en) * 2006-12-11 2008-07-16 Universiteit Utrecht Holding B.V. Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof
US20090047336A1 (en) * 2007-08-17 2009-02-19 Hong Kong Baptist University novel formulation of dehydrated lipid vesicles for controlled release of active pharmaceutical ingredient via inhalation
US8962015B2 (en) * 2007-09-28 2015-02-24 Sdg, Inc. Orally bioavailable lipid-based constructs
CN101485629B (zh) * 2008-01-16 2013-01-23 沈阳药科大学 一种给药系统及其制备方法
JP5903268B2 (ja) * 2008-07-24 2016-04-13 アモーレパシフィック コーポレイションＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ 多層ラメラ顆粒、及びこれを含有する皮膚外用剤組成物
CA2754896C (en) * 2009-03-09 2017-11-28 Molecular Express, Inc. Methods and compositions for liposomal formulation of antigens and uses thereof
US9775819B2 (en) 2009-09-16 2017-10-03 R.P. Scherer Technologies, Llc Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
EP2386647A1 (de) * 2010-05-10 2011-11-16 Qiagen GmbH Verfahren zur Transfektion einer eurkaryotischen Zelle
EP2471511A1 (en) 2011-01-04 2012-07-04 Archivel Farma, SL Liposome formulation suitable for treating or preventing tuberculosis
SI2768484T1 (sl) 2011-10-21 2019-12-31 Jazz Pharmaceuticals Research Llc Liofilizirani liposomi
US10076496B2 (en) * 2011-11-11 2018-09-18 The Chinese University Of Hong Kong Engineering of polymer-stabilized nanoparticles for drugs with Log P values below 6 by controlled antisolvent precipitation
EA022183B1 (ru) * 2012-12-24 2015-11-30 Общество С Ограниченной Ответственностью "Технология Лекарств" Способ получения липосомальной формы цитохрома с
US11504322B2 (en) 2014-08-28 2022-11-22 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
US11471401B2 (en) 2014-08-28 2022-10-18 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
AU2015308790B2 (en) 2014-08-28 2020-12-03 The General Hospital Corporation Compositions and methods for treatment of neurological disorders
KR20180122642A (ko) 2016-02-26 2018-11-13 더 제너럴 하스피탈 코포레이션 의료용 빙류 슬러리 제조 및 전달 시스템 및 방법
WO2021016457A1 (en) * 2019-07-24 2021-01-28 The General Hospital Corporation Methods of creating a substance with different freezing points by encapsulation
CN114886785B (zh) * 2022-06-07 2023-02-03 美尚(广州)化妆品股份有限公司 一种三元冻干组合物及其在冻干制剂中的应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
CH621479A5 (no) * 1977-08-05 1981-02-13 Battelle Memorial Institute
US4460577A (en) * 1977-09-30 1984-07-17 Farmitalia Carlo Erba S.P.A. Pharmaceutical compositions consisting or consisting essentially of liposomes, and processes for making same
FR2416008A1 (fr) * 1978-02-02 1979-08-31 Oreal Lyophilisats de liposomes
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4193983A (en) * 1978-05-16 1980-03-18 Syva Company Labeled liposome particle compositions and immunoassays therewith
US4377567A (en) * 1978-10-02 1983-03-22 The Procter & Gamble Company Lipid membrane drug delivery
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations
JPS574913A (en) * 1980-06-11 1982-01-11 Green Cross Corp:The Urokinase preparation for oral administration
JPS5746921A (en) * 1980-09-02 1982-03-17 Green Cross Corp:The Oral preparation of human blood coagulation factor
US4460560A (en) * 1982-06-18 1984-07-17 University Of Southern California Drug delivery by polymeric carriers
US4568545A (en) * 1982-10-02 1986-02-04 Amano Seiyaku Kabushiki Kaisha Thrombolytic agent
US4544545A (en) * 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US4914084A (en) * 1984-05-09 1990-04-03 Synthetic Blood Corporation Composition and method for introducing heme, hemoproteins, and/or heme-hemoprotein complexes into the body
US5008109A (en) * 1984-05-25 1991-04-16 Vestar, Inc. Vesicle stabilization
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
EP0208764A4 (en) * 1985-01-11 1987-10-08 Univ California PRESERVATION PROCEDURE FOR LIPOSOME.
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
CA1256372A (en) * 1985-04-11 1989-06-27 Koichiro Miyazima Process for producing liposome composition
US4735210A (en) * 1985-07-05 1988-04-05 Immunomedics, Inc. Lymphographic and organ imaging method and kit
US4766046A (en) * 1985-09-27 1988-08-23 Liposome Technology, Inc. Stabilized liposome/amphotericin composition and method
IE58981B1 (en) * 1985-10-15 1993-12-15 Vestar Inc Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
GB8604983D0 (en) * 1986-02-28 1986-04-09 Biocompatibles Ltd Protein preservation
US5089181A (en) * 1987-02-24 1992-02-18 Vestar, Inc. Method of dehydrating vesicle preparations for long term storage
EP0395765A4 (en) * 1988-01-13 1991-09-25 Dainippon Pharmaceutical Co., Ltd. Oozing-proof liposome preparation
JPH02273538A (ja) * 1989-04-13 1990-11-08 Fuji Photo Film Co Ltd リポソームの保存方法
US5705187A (en) * 1989-12-22 1998-01-06 Imarx Pharmaceutical Corp. Compositions of lipids and stabilizing materials

Also Published As

Publication number Publication date
IL91901A0 (en) 1990-06-10
DK59691D0 (da) 1991-04-04
WO1990003795A1 (en) 1990-04-19
CA2000219A1 (en) 1990-04-05
EP0437479A4 (en) 1991-10-16
IE64559B1 (en) 1995-08-23
US5817334A (en) 1998-10-06
IE893196L (en) 1990-04-05
AU612285B2 (en) 1991-07-04
DK59691A (da) 1991-04-04
EP0437479B1 (en) 1994-06-22
AU4340089A (en) 1990-05-01
NO180363C (no) 1997-04-09
FI902249A0 (fi) 1990-05-04
DE68916439T2 (de) 1994-10-20
DE68916439D1 (de) 1994-07-28
NO901852L (no) 1990-08-01
IL91901A (en) 1993-06-10
NO180363B (no) 1996-12-30
ATE107502T1 (de) 1994-07-15
JPH04500803A (ja) 1992-02-13
EP0437479A1 (en) 1991-07-24
JP2792702B2 (ja) 1998-09-03

Similar Documents

Publication Publication Date Title
NO901852D0 (no) Fremgangsmaate for fremstilling av liposomer.
HK160895A (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
HUT52341A (en) Method for producing preparations
DE3852116D1 (de) Herstellung von Proteinen in aktiver Form.
EP0141374A3 (en) Capsule production using biologically active substrates
CA2113995A1 (en) Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins
DE3772498D1 (de) Phospholipidpartikeln mit eingeschlossenen polyen-antibiotika zur behandlung von systemischen pilzinfektionen.
TR199802789T2 (xx) Eksendin analoglar� bunlar�n �retimi i�in y�ntemler ve bunlar� i�eren farmas�tik m�stahzarlar.
ES8306023A1 (es) Procedimiento para la fabricacion de un aglutinante para tejidos a base de proteinas humanas o animales.
HK160995A (en) Complex compounds of bioflavonoids with phospholipids their preparation and use and pharmaceutical and cosmetic compositions containing them
NO170126C (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater i form av suspensjoner som inneholder sucralfat
ES8305501A1 (es) Procedimiento para preparar un material de referencia o control de hemoglobina.
HUT39971A (en) Pesticide compositions containing 3,5-diaryl-1,2,4-triazole derivatives as active ingredients and process for preparing the active substances
NO914206L (no) Terapeutisk middel
HUT44401A (en) Pesticides comprising substituted hydrazones as active substance and process for preparing the active substance
TR199902025T2 (xx) Suda ileri derecede ��z�nmez olan bir etken maddeyi hapseden liyofilize lipozomlar i�eren farmas�tik preparasyon ve bu preparasyonu haz�rlamak i�in i�lem.
HUP9900506A2 (hu) Protrombinszármazékok
HUT34766A (en) Process for producing new, natural lb-rh antagonistic peptides and erivatives, ndpharmaceutical compositions containing them as active ingredients
HUT35155A (en) Pesticide composition containing heterocyclic nitro-methylene derivatives as active substances and process for preparing the active substance
GR3029581T3 (en) Liposomes containing encapsulated proteins, method of preparing them and pharmaceutical and cosmetic preparations containing such liposomes
DE3372765D1 (en) Carbamic-acid esters, process and starting material for their preparation, parasiticides containing these esters as active products, as well as the use of such esters and agents in combating parasites
IT1186775B (it) Derivati nuobosidici aventi proprieta' antierpetiche,composizioni farmaceutiche che li contengono e procedimento per la preparazione degli ingredienti attivi
HUT36355A (en) Pesticide compositions containing n-oxalyl derivatives of n-methyl-carbamates as active substances and process for preparing the active substances
IL88836A0 (en) Method of obtaining antivirally active proteins,antivirally active proteins and compositions containing them
ES425250A1 (es) Un metodo para preparar una capsula de gelatina con buenas propiedades de desintegracion.